Jay Venkatesan, See Remarks at Angion Biomedica Corp. (ANGN), bought 3,527 shares at $2.54 ($9K) on 2021-12-20, disclosed to the SEC on 2021-12-22.
Open-market purchase of $9k ANGN by See Remarks. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| ANGN | BUY | 2022-05-25 | $101K | — | Filing → |
| ANGN | BUY | 2021-12-29 | $1.5M | — | Filing → |
| ANGN | BUY | 2021-12-20 | $177K | — | Filing → |